Aptevo Therapeutics Inc. (APVO) Insider Trading Activity

NASDAQ$1.34-0.02 (-1.47%)
Market Cap
$2.97M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
350 of 849
Rank in Industry
205 of 491

APVO Insider Trading Activity

APVO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$20,134
1
100
Sells
$0
0
0

Related Transactions

Grant Grady IIIdirector
1
$20,134
0
$0
$20,134

About Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost investigational drug, APVO436, is a bispecific antibody crafted to engage T-cells, which is currently undergoing a Phase 1b clinical study for acute myeloid leukemia and myelodysplastic syndromes. Beyond its lead asset, Aptevo's research pipeline encompasses several preclinical compounds. These include ALG.APV-527, an experimental bispecific ADAPTIR …

Insider Activity of Aptevo Therapeutics Inc.

Over the last 12 months, insiders at Aptevo Therapeutics Inc. have bought $20,134 and sold $0 worth of Aptevo Therapeutics Inc. stock.

On average, over the past 5 years, insiders at Aptevo Therapeutics Inc. have bought $20,134 and sold $16.87M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Grant Grady III (director) — $20,134.

The last purchase of 13,513 shares for transaction amount of $20,134 was made by Grant Grady III (director) on 2025‑11‑10.

List of Insider Buy and Sell Transactions, Aptevo Therapeutics Inc.

2025-11-10PurchaseGrant Grady IIIdirector
13,513
0.2374%
$1.49
$20,134
-83.12%
2021-11-23SaleTANG KEVIN C
921,336
12.987%
$11.25
$10.37M
-53.44%
2021-11-22SaleTANG KEVIN C10 percent owner
255,331
5.9122%
$7.03
$1.8M
+22.69%
2021-11-19SaleTANG KEVIN C10 percent owner
213,800
4.7422%
$7.59
$1.62M
+8.63%
2021-11-18SaleTANG KEVIN C10 percent owner
369,533
8.1153%
$8.34
$3.08M
-2.28%
2020-11-06PurchaseTANG KEVIN C10 percent owner
348,554
7.5668%
$22.73
$7.92M
+76.94%
2020-11-05PurchaseTANG KEVIN C10 percent owner
1.25M
25.0765%
$18.78
$23.5M
+95.99%
2020-11-04PurchaseTANG KEVIN C10 percent owner
1.27M
24.3464%
$14.34
$18.27M
+143.14%
2019-08-16PurchaseMaddux Randy JoeSVP Operations, CMO
50,000
0.1097%
$0.76
$38,000
-26.15%
2019-08-12PurchaseEl-Hibri Fuaddirector
200,000
0.4342%
$0.76
$151,040
-26.44%
2019-07-29PurchaseEl-Hibri FuadBoard of Directors
110,030
0.2409%
$0.83
$91,721
-32.81%
2019-07-23PurchaseEl-Hibri FuadBoard of Directors
20,000
0.0452%
$0.90
$17,992
-35.71%
2019-07-22PurchaseEl-Hibri FuadBoard of Directors
60,000
0.1331%
$0.89
$53,202
-36.00%
2019-07-19PurchaseEl-Hibri FuadBoard of Directors
52,920
0.1212%
$0.90
$47,480
-36.72%
2019-07-18PurchaseEl-Hibri FuadBoard of Directors
28,808
0.0638%
$0.87
$25,193
-37.15%
2019-07-17PurchaseEl-Hibri FuadBoard of Directors
38,272
0.085%
$0.87
$33,408
-36.86%
2019-07-16PurchaseEl-Hibri FuadBoard of Directors
22,750
0.0486%
$0.85
$19,324
-37.58%
2019-07-11PurchaseEl-Hibri FuadBoard of Directors
29,382
0.0649%
$0.85
$24,907
-35.30%
2019-07-10PurchaseEl-Hibri Fuaddirector
37,838
0.0843%
$0.85
$32,117
-34.84%
2019-06-25PurchaseAbdun-Nabi DanielBoard of Directors
33,334
0.0753%
$0.90
$30,001
-47.32%
Total: 33
*Gray background shows transactions not older than one year

APVO Institutional Investors: Active Positions

Increased Positions8+50%19,652+71.58%
Decreased Positions8-50%26,808-97.64%
New Positions5New16,883New
Sold Out Positions5Sold Out26,661Sold Out
Total Postitions160%20,299-26.06%

APVO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Point72 Asset Management, L.P.$156.001.67%16,665+16,665New2025-09-30
Drw Securities, Llc$69.000.73%7,305+7,305New2025-09-30
Virtu Financial Llc$20.000.21%2,127+2,127New2025-09-30
Focus Partners Wealth$5.000.06%556+556New2025-09-30
Osaic Holdings, Inc.$3.000.04%361+180+99.45%2025-09-30
Ubs Group Ag$3.000.03%315+315New2025-09-30
Tower Research Capital Llc (Trc)$1.000.01%80+14+21.21%2025-09-30
Sbi Securities Co., Ltd.$0<0.01%32<1-3.03%2025-09-30
Citigroup Inc$00%4+4New2025-09-30
Bank Of America Corp /De/$00%2+2New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.